Cargando…
PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large backgrou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151198/ https://www.ncbi.nlm.nih.gov/pubmed/25228907 http://dx.doi.org/10.3389/fgene.2014.00305 |
_version_ | 1782333008433381376 |
---|---|
author | Demeure, Kevin Duriez, Elodie Domon, Bruno Niclou, Simone P. |
author_facet | Demeure, Kevin Duriez, Elodie Domon, Bruno Niclou, Simone P. |
author_sort | Demeure, Kevin |
collection | PubMed |
description | The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large background variability observed in patient material. As an alternative approach, human tumors orthotopically implanted into a different species (xenografts) are clinically relevant models that have proven their utility in pre-clinical research. Patient derived xenografts for glioblastoma have been extensively characterized in our laboratory and have been shown to retain the characteristics of the parental tumor at the phenotypic and genetic level. Such models were also found to adequately mimic the behavior and treatment response of human tumors. The reproducibility of such xenograft models, the possibility to identify their host background and perform tumor-host interaction studies, are major advantages over the direct analysis of human samples. At the proteome level, the analysis of xenograft samples is challenged by the presence of proteins from two different species which, depending on tumor size, type or location, often appear at variable ratios. Any proteomics approach aimed at quantifying proteins within such samples must consider the identification of species specific peptides in order to avoid biases introduced by the host proteome. Here, we present an in-house methodology and tool developed to select peptides used as surrogates for protein candidates from a defined proteome (e.g., human) in a host proteome background (e.g., mouse, rat) suited for a mass spectrometry analysis. The tools presented here are applicable to any species specific proteome, provided a protein database is available. By linking the information from both proteomes, PeptideManager significantly facilitates and expedites the selection of peptides used as surrogates to analyze proteins of interest. |
format | Online Article Text |
id | pubmed-4151198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-41511982014-09-16 PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species Demeure, Kevin Duriez, Elodie Domon, Bruno Niclou, Simone P. Front Genet Genetics The search for clinically useful protein biomarkers using advanced mass spectrometry approaches represents a major focus in cancer research. However, the direct analysis of human samples may be challenging due to limited availability, the absence of appropriate control samples, or the large background variability observed in patient material. As an alternative approach, human tumors orthotopically implanted into a different species (xenografts) are clinically relevant models that have proven their utility in pre-clinical research. Patient derived xenografts for glioblastoma have been extensively characterized in our laboratory and have been shown to retain the characteristics of the parental tumor at the phenotypic and genetic level. Such models were also found to adequately mimic the behavior and treatment response of human tumors. The reproducibility of such xenograft models, the possibility to identify their host background and perform tumor-host interaction studies, are major advantages over the direct analysis of human samples. At the proteome level, the analysis of xenograft samples is challenged by the presence of proteins from two different species which, depending on tumor size, type or location, often appear at variable ratios. Any proteomics approach aimed at quantifying proteins within such samples must consider the identification of species specific peptides in order to avoid biases introduced by the host proteome. Here, we present an in-house methodology and tool developed to select peptides used as surrogates for protein candidates from a defined proteome (e.g., human) in a host proteome background (e.g., mouse, rat) suited for a mass spectrometry analysis. The tools presented here are applicable to any species specific proteome, provided a protein database is available. By linking the information from both proteomes, PeptideManager significantly facilitates and expedites the selection of peptides used as surrogates to analyze proteins of interest. Frontiers Media S.A. 2014-09-02 /pmc/articles/PMC4151198/ /pubmed/25228907 http://dx.doi.org/10.3389/fgene.2014.00305 Text en Copyright © 2014 Demeure, Duriez, Domon and Niclou. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Demeure, Kevin Duriez, Elodie Domon, Bruno Niclou, Simone P. PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title | PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title_full | PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title_fullStr | PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title_full_unstemmed | PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title_short | PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
title_sort | peptidemanager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151198/ https://www.ncbi.nlm.nih.gov/pubmed/25228907 http://dx.doi.org/10.3389/fgene.2014.00305 |
work_keys_str_mv | AT demeurekevin peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies AT duriezelodie peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies AT domonbruno peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies AT niclousimonep peptidemanagerapeptideselectiontoolfortargetedproteomicstudiesinvolvingmixedsamplesfromdifferentspecies |